Citadel Advisors - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459958. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$263,000
-19.1%
19,600
-15.5%
0.00%
Q3 2015$325,000
+38.9%
23,200
+68.1%
0.00%
Q2 2015$234,000
+154.3%
13,800
+81.6%
0.00%
Q1 2015$92,000
-3.2%
7,600
-33.9%
0.00%
Q4 2014$95,000
-5.9%
11,500
-0.9%
0.00%
Q3 2014$101,000
-68.4%
11,600
-60.3%
0.00%
Q2 2014$320,000
-29.7%
29,200
-42.6%
0.00%
-100.0%
Q1 2014$455,000
+193.5%
50,900
+147.1%
0.00%
Q4 2013$155,000
+1191.7%
20,600
+1187.5%
0.00%
Q3 2013$12,0001,6000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 4,000$101,0000.00%
SIMPLEX TRADING, LLC 9$22,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders